| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/20/2008 | EP1349560A4 Black tea extract for prevention of disease |
| 02/20/2008 | EP1305310B1 Tartrate salts of thiazolidinedione derivative |
| 02/20/2008 | EP1285947B1 Antimicrobial composition |
| 02/20/2008 | EP1177166B1 Process for preparing (1r,2s,4r) -(-)-2- (2'- n,n-dimethylamino -ethoxy) -2- phenyl -1,7,7-tri- methyl -bicyclo 2.2.1 heptane and pharmaceutically acceptable acid addition salts thereof |
| 02/20/2008 | EP1175411B1 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 02/20/2008 | EP1171124B1 Anthelmintic compositions |
| 02/20/2008 | EP1166784B1 Inhibition of vascular restenosis after angioplasty |
| 02/20/2008 | EP1131290B1 Piperidine ccr-3 receptor antagonists |
| 02/20/2008 | EP1127059B1 Imidazonaphthyridines |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | EP1101497B1 Stabilized oily preparations of tobicillin (beta-lactam antibiotic) |
| 02/20/2008 | EP1071422B1 Association of Riluzole and levodopa for the treatment of Parkinson disease |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0975347B1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/20/2008 | EP0951281B9 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR |
| 02/20/2008 | EP0938315B9 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 02/20/2008 | EP0870500B1 Anti-helicobacter pylori agent |
| 02/20/2008 | EP0855906B1 Insoluble drug delivery |
| 02/20/2008 | EP0644877B1 Substituted-hexahydrobenzo a phenanthridines |
| 02/20/2008 | CN101128734A Systems and methods for assessing neuronal degeneration |
| 02/20/2008 | CN101128476A 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 02/20/2008 | CN101128474A Tricyclic-nucleoside prodrugs for treating viral infections |
| 02/20/2008 | CN101128473A Adenosine derivatives having a2a receptor activity |
| 02/20/2008 | CN101128470A New compounds |
| 02/20/2008 | CN101128469A 蛋白酶抑制剂前体的合成 Synthetic precursor protease inhibitors |
| 02/20/2008 | CN101128468A An efficient and stereoselective process for large scale synthesis of 3-(R)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-B}quinolin-9-one |
| 02/20/2008 | CN101128461A Imidazo (1, 2-a) pyridine compounds as VEGF-R2 inhibitors |
| 02/20/2008 | CN101128460A Tricyclic delta-opioid modulators |
| 02/20/2008 | CN101128458A Tricyclic delta-opioid modulators |
| 02/20/2008 | CN101128456A Quinazoline derivatives as tyrosine kinase inhibitors |
| 02/20/2008 | CN101128455A Heterocyclylamide-substituted imidazoles |
| 02/20/2008 | CN101128454A Pyridine carboxamide derivatives for use as anticancer agents |
| 02/20/2008 | CN101128453A 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| 02/20/2008 | CN101128452A Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same |
| 02/20/2008 | CN101128451A Derivatives of n-[(4,5-diphenyl-2-thienyl)methyl]amine, their preparations and therapeutic application |
| 02/20/2008 | CN101128447A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 02/20/2008 | CN101128444A New pharmaceutically-active compounds for the treatment of respiratory diseases |
| 02/20/2008 | CN101128441A Fused aromatic compounds having anti-diabetic activity |
| 02/20/2008 | CN101128440A Hydrazinomethyl, hydr zonomethyl and 5-membered heterocyclic compounds which act as mTOR inhibitors and their use as anti cancer agents |
| 02/20/2008 | CN101128438A Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds |
| 02/20/2008 | CN101128434A Amide derivatives |
| 02/20/2008 | CN101128433A Isoquinoline derivatives as calpain inhibitors |
| 02/20/2008 | CN101128431A Novel quinoline derivatives as potassium ion channel openers |
| 02/20/2008 | CN101128430A Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 02/20/2008 | CN101128429A Nk1拮抗物 Nk1 antagonist |
| 02/20/2008 | CN101128428A Novel pyridine derivatives as potassium ion channel openers |
| 02/20/2008 | CN101128427A Heterocyclic compounds as ccr2b antagonists |
| 02/20/2008 | CN101128425A Dimeric IAP inhibitors |
| 02/20/2008 | CN101128424A 吲哚化合物及其用途 Indole compounds and their use |
| 02/20/2008 | CN101128423A Novel lipoxygenase inhibitors |
| 02/20/2008 | CN101128420A Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof |
| 02/20/2008 | CN101128418A Diastereoisomers of 4-hydroxyisoleucine and uses thereof |
| 02/20/2008 | CN101128417A Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride |
| 02/20/2008 | CN101128211A Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia |
| 02/20/2008 | CN101128208A Formulations and treatments for trichology |
| 02/20/2008 | CN101128207A Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 02/20/2008 | CN101128206A Tetracycline metal complex in a solid dosage form |
| 02/20/2008 | CN101128205A Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release |
| 02/20/2008 | CN101128204A 2,4-diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors |
| 02/20/2008 | CN101128203A Composition comprising ocaperidone |
| 02/20/2008 | CN101128202A Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| 02/20/2008 | CN101128201A Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases |
| 02/20/2008 | CN101128200A Composition for inhibition of cathepsin K |
| 02/20/2008 | CN101128199A Monocyclic heterocycles as kinase inhibitors |
| 02/20/2008 | CN101128198A Combination of sabcomeline with a neuroleptic agent to treat psychotic disorders |
| 02/20/2008 | CN101128197A Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
| 02/20/2008 | CN101128196A Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases |
| 02/20/2008 | CN101128195A Bicalutamide for sending increased steady state blood plasma level |
| 02/20/2008 | CN101128194A Preventive antistress agent |
| 02/20/2008 | CN101128193A Anti-radical agents |
| 02/20/2008 | CN101128192A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 02/20/2008 | CN101128191A Dosage form containing oxycodone and naloxone |
| 02/20/2008 | CN101128188A Formulations of substituted benzoxazoles |
| 02/20/2008 | CN101128185A Aqueous topical gel of high stability based on metronidazole and method of preparation |
| 02/20/2008 | CN101128136A Method of treatment of skin using a benefit agent and an apparatus |
| 02/20/2008 | CN101128117A Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids |
| 02/20/2008 | CN101128114A 18-membered macrocycles and analogs thereof |
| 02/20/2008 | CN101125926A Terminal amido group start-type poly (lactic-co-glycolic acid)/polyglycol block copolymer, preparation method, medicament-carried nano micelle and application |
| 02/20/2008 | CN101125880A Bindwood sapogenin and its preparation method and use |
| 02/20/2008 | CN101125871A Sulfuric acid azithromycin, application thereof, freeze dried of the sulfuric acid azithromycin and preparation method for the freeze dried |
| 02/20/2008 | CN101125870A Synthesis for 3-(4-beta-D-pyranalloseglycoside-phenyl)-4-aryl-5-aryl-1,2,4-oxadiazoline |
| 02/20/2008 | CN101125865A Chiral ruthenium complex and application of the same used as antineoplastic |
| 02/20/2008 | CN101125864A Heteroaromatic inhibitor for fructose-1,6-bisphosphatase |
| 02/20/2008 | CN101125855A Method for separating hemporfin isomer and separated isomer |
| 02/20/2008 | CN101125853A Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/20/2008 | CN101125852A Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/20/2008 | CN101125851A Novel pharmaceutical |
| 02/20/2008 | CN101125850A Andrographolide derivatives and application of the same in pharmacy |
| 02/20/2008 | CN101125848A A process for preparing duloxetine and intermediates for use therein |
| 02/20/2008 | CN101125846A Preparation method for medicament compound brasilein and use thereof |
| 02/20/2008 | CN101125842A Separation and identification for novel flavonoid compounds in bruguiera gymnoihiza and antineoplastic use thereof |
| 02/20/2008 | CN101125837A C-glycosides type slycolipid compounds and use thereof |
| 02/20/2008 | CN101125836A Costene lactone derivative and medical use thereof |
| 02/20/2008 | CN101125289A Method for preparing anti-oxidant bio-microcapsule |
| 02/20/2008 | CN101125201A Medicine composition for treating osteoporosis or preventing bone fracture caused by osteoporosis and its application |
| 02/20/2008 | CN101125196A External applied medicine for treating lumbar vertebra, cervical vertebra and osteoarthrilis |
| 02/20/2008 | CN101125190A Powdered medicine active carbon mixture and preparation method thereof |
| 02/20/2008 | CN101125179A Wound-healing muscle-growing ointment and production method thereof |
| 02/20/2008 | CN101125166A External-applied traditional Chinese medicine for treating rheumatism |
| 02/20/2008 | CN101125165A Traditional Chinese medicine for treating deaf |